ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 01 Oct 2024
Last Applicant/ Owned by
3160 NW 1 Ave
Pompano Beach
FL
33064
Serial Number
98303327 filed on 07th Dec 2023
Registration Number
N/A
Correspondent Address
Pompano Beach, FL 33064
United States
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
THE GENOMICS LANGUAGE COMPANY
mRNA Inflammatory Index (patent pending) is an assay that measures 48 different biomarkers for chronic inflammation that may be directly related to the development of chronic illnesses such as COPD, Heart Disease, Diabetes and various Cancers. Combined with AI and Deep Machine Learning this technology may unlock the key to preventing chronic illnesses that, according to the World Health Organizati Read More
Classification Information
Class [009]
Computer & Software Products & Electrical & Scientific Products
mRNA Inflammatory Index (patent pending) is an assay that measures 48 different biomarkers for chronic inflammation that may be directly related to the development of chronic illnesses such as COPD, Heart Disease, Diabetes and various Cancers. Combined with AI and Deep Machine Learning this technology may unlock the key to preventing chronic illnesses that, according to the World Health Organization cause 50% of the world's deaths.
First Use Date in General
03rd Sep 2022
First Use Date in Commerce
03rd Sep 2022
Mark Details
Serial Number
No 98303327
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Oct 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 01st Oct 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 17th Jun 2024 | NON-FINAL ACTION WRITTEN |
| 17th Jun 2024 | NON-FINAL ACTION E-MAILED |
| 17th Jun 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 12th Jun 2024 | ASSIGNED TO EXAMINER |
| 05th Mar 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 07th Dec 2023 | NEW APPLICATION ENTERED |